¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acid Mantle Top"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
  • N-acetylneuraminic acid
    N-¾Æ¼¼Æ¿´º¶ó¹Î»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • pantoic acid
    ÆÇÅäÀλê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • picramic acid
    ÇÇÅ©¶÷»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saccharic acid
    »çÄ«¸°»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated acid
    Æ÷È­Áö¹æ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • free acid
    À¯¸®»ê(ë´ìÆß«).
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • fuming sulfuric acid
    ¹ß¿¬È²»ê(¡­üÜß«).
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glacial acetic acid
    ºùÃÊ»ê.
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glutamic acid
    ±Û·çŽ»ê.
  • glutamic acid dehydrogenase
    ±Û·çŽ»êÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çŽ»êµ¥È÷µå·Î°Ô<³ª>Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • boric acid ointment
    ºØ»ê¿¬°í(¡­æãÍÇ).
  • boric acid solution
    ºØ»ê¼ö(ÝÝß«â©).
  • branched chain amino acid
    ºÐÁö¼â¾Æ¹Ì³ë»ê
  • butyric acid
    ºÎƼ¸£»ê.
  • cacodylic acid
    Ä«ÄÚµô»ê.
  • caffeic acid
    Ä«ÆäÀλê
  • carbolic acid =phenol
    Ä«¸£º¼»ê(¡­ß«).
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú (¡­ÎÕîÅ).
  • carbolic acid water
    ¼®Åº»ê¼ö(¡­ß«â©).
  • carbonic acid
    ź»ê.
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê(÷©ß«)
  • carbonic acid assimilation
    ź¼Òµ¿È­ (¡­ÔÒûù).
  • cell wall teichoic acid
    ¼¼Æ÷º® ŸÀÌÄÚ»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • essential fatty acid
    Çʼö Áö¹æ»ê (ù±âÎò·Û¸ß«)
  • ethylenediaminetetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)¾Æ¹Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • ethylenedinitrolotetraacetic acid
    ¿¡Æ¿·»ÀÌ(ì£)³ªÀÌÆ®·Î»ç(ÞÌ)¾Æ¼¼Æ®»ê(ß«)
  • even-numbered fatty acid
    ¦¼ö Áö¹æ»ê(ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid activating enzyme
    Áö¹æ»ê Ȱ¼ºÈ­ È¿¼Ò (ò·Û¸ß«üÀàõûùý£áÈ)
  • fatty acid activation
    Áö¹æ»ê Ȱ¼ºÈ­ (ò·Û¸ß«üÀàõûù)
  • fatty acid CoA ligase
    Áö¹æ»ê(ò·Û¸ß«) CoA ¶óÀ̰ÔÀ̽º
  • fatty acid oxidation
    Áö¹æ»ê »êÈ­ (ò·Û¸ß«ß«ûù)
  • fatty acid synthetase system
    Áö¹æ»ê ÇÕ¼º È¿¼Ò(ò·Û¸ß«ùêà÷ý£áÈ)½Ã½ºÅÛ
  • fatty acid thiokinase
    Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • folic acid
    Æú»ê(ß«)
  • folic acid coenzyme
    Æú»ê(ß«) º¸È¿¼Ò(ÜÍý£áÈ)
  • folic acid conjugate
    Æú»ê(ß«) Æ÷ÇÕü(øÙùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
LA lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left...
LAD lactic acid dehydrogenase; left anterior descending [artery]; left axis deviation; leukocyte adhesio...
MA malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern...
PAP pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa...
PAS para aminosalicylate; Parent Attitude Scale; patient administration system; patient appointments and...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
HODE 13(S)-hydroxyoctadecadienoic acid
13APA 13-Azaprostanoic acid
13CRA 13-CIS-RETINOIC ACID
CRA 13-cis retinoic acid
RA 13-cis-Retinoic Acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malic acid
    ´É±Ý»ê
    µ¿ÀǾî=hydroxysuccinic acid. Æ®¶óÀÌÄ«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£ ¹°Áú. ´ú ÀÍ°í ½Å »ç°ú¿Í ´Ù¸¥ ¸¹Àº °ú½Ç ¼Ó¿¡ µé¾îÀÖ´Ù. ±«Ç÷º´ÀÇ Ä¡·á¿¡ »ç¿ëµÇ±âµµ ÇÑ´Ù.
  • malonic acid
    ¸»·Ð»ê
    °áÁ¤¼ºÀÇ ÀÌ¿°±â»ê.
  • meclofenamic acid
    ¸ÞŬ·ÎÆä³ª¹Ìµå»ê
    °ñ°üÀý¿° ¹× ·ù¸¶ÅäÀÌµå °üÀý¿°ÀÇ Ä¡·á¿¡ meclofenamate sodiumÀ¸·Î »ç¿ëµÈ´Ù.
  • meconic acid
    ¸ÞÄÜ»ê
    ¹é»ö °áÁ¤¼º »ê.
  • mefenamic acid
    ¸ÞÆä³²»ê
    °áÁ¤¼º ºÐ¸», ÇÔ¿°ÁõÁ¦.
  • messenger ribonucleic acid
    Àü·É RNA
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metaphosphoric acid
    ¸ÞŸÀλê
    ÀλêÀÇ Çϳª. Çü»óÀ¸·Î º¸¾Æ À¯¸®»ó ÀÎ»ê ¶Ç´Â ºù»ó ÀλêÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ½Ä HPO. ¹Ì»ý¹°, °ïÃæ·ù ¶Ç´Â ¾î¶² Á¾·ùÀÇ µ¿¹°ÀÇ Á¶Á÷ µî¿¡ Á¸ÀçÇÑ´Ù. ¹«»ö Åõ¸íÇÑ À¯¸®»ó °íü ¶Ç´Â ºÎµå·¯¿î ºñ´Ü½Ç ¸ð¾çÀÇ ±«»ó ¹°Áú·Î, ºÐÀÚ·® 79.98, ºñÁß 2.2ÀÌ´Ù. Á¶ÇؼºÀ̸ç, ½ÀÇÑ °ø±â ¼Ó¿¡ ¹æÄ¡ÇÏ¸é ¿À¸£Åä Àλê HPO°¡ µÈ´Ù. ¹°, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. °¡¿­ÇÏ¸é ¿ëÀ¶ÇÏ¿© Á¡¼ºµµ°¡ Áõ°¡ÇÏ°í ´õ¿í °¡¿­ÇÏ¸é ½ÂÈ­ÇÑ´Ù. ¼ö¿ë¾× ¼Ó¿¡¼­´Â ÁßÇÕü¸¦ Àß ¸¸µé°í, °£´ÜÇÑ °Íµµ »ïÇÕü³ª »çÇÕü°¡ µÇÁö¸¸, Àå½Ã°£ ¹æÄ¡ÇÏ¸é ¿À¸£ÅäÀλêÀ¸·Î º¯ÇÑ´Ù. ¸ÞŸÀÎ»ê ¿ë¾×¿¡ Áú»ê Àº ¿ë¾×À» °¡ÇÏ¸é ¹é»ö ħÀüÀÌ »ý±ä´Ù. ¸ÞŸÀλêÀº ¿À¸£ÅäÀÎ»ê ¶Ç´Â ÇÇ·ÎÀλê HPOÀ» 300 ¡É ÀÌ»óÀ¸·Î °¡¿­ÇÏ¸é »ý±ä´Ù. 2HPO 2j HPO+HO HPO 2j 2HPO+HO ¶Ç ¿À»êÈ­ÀÎÀ» 0 ¡É ÀÌÇÏ·Î ¼öÈ­ÇØµµ ¾ò´Â´Ù. Ä¡°ú¿ë ½Ã¸àÆ® , È­Çкм®¿ë ½Ã¾à, º¸ÀÏ·¯ ûÁ¤Á¦, ÀμâÁ¦ÆÇ, °¡Á×ÀÇ ¹«µÎÁú µî¿¡ ¾²À̸ç, Ä®·ý¿°Àº À¯Á¦Ç°ÀÇ Á¡¼ºµµ Áõ°¡Á¦, ¼¼Á¦, ÇÜ, ¼Ò½ÃÁöÀÇ Ã·°¡Á¦·Î »ç¿ëµÈ´Ù. ¶ÇÇÑ, ¸ÞŸÀλêÀº »ý¹°ÇлóÀ¸·Îµµ ¸Å¿ì Èï¹Ì·Î¿î ¼ºÁúÀ» °¡Áö°í Àִµ¥, È¿¸ð¿¡¼­´Â ÇÙ»êÀÇ ÇÕ¼º¿¡ ÇÊ¿äÇÑ Àΰú ¿¡³ÊÁö¸¦ ¸ÞŸÀλêÀÌ °ø±ÞÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • methacrylic acid
    ¸ÞŸ ¾ÆÅ©¸¯ »ê
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
amino acid activation The first step of protein synthesis, whereby an amino acid reacts with adenosine triphosphate in the presence of aminoacyl RNA synthetase to produce an amino acid adenylate, which provides the energy necessary for the attachment of the amino acid to a specific transfer RNA molecule.
(12 Dec 1998)
amino acid analysis Determination and identification of amino acid content of a macromolecule, identification of a specific amino acid in macromolecules, often a mutated protein, identification and quantitation of amino acid content in blood plasma or urine; a key diagnostic aid.
(05 Mar 2000)
amino acid chloromethyl ketones <chemical> Inhibitors of serine proteinases and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.
Pharmacological action: alkylating agents, protein synthesis inhibitor, serine proteinase inhibitors.
(12 Dec 1998)
amino acid dehydrogenases Enzymes catalyzing the oxidative deamination of amino acids to the corresponding oxo (keto) acids; two relatively non-specific varieties exist, l and d, for which l-amino acids and d-amino acids are the respective substrates; the products include NH3 and a reduced hydrogen acceptor (NADH in the l case); amino acid dehydrogenases of greater specificity exist, (e.g., glycine dehydrogenase).
Compare: amino acid oxidases.
(05 Mar 2000)
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á